Left atrial appendage occlusion in high-risk patients with non-valvular atrial fibrillation.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Percutaneous left atrial appendage (LAA) occlusion has been developed as a viable option for stroke and thromboembolism prevention in patients with non-valvular atrial fibrillation (NVAF) and at high risk for cerebral cardioembolic events. Data on device implantation and long-term follow-up from large cohorts are limited.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Heart

Title: Heart (British Cardiac Society)

Publisher: BMJ

ISSN (Electronic): 1468-201X

ISSN (Print): 1355-6037

Publication date (Electronic): December 15 2016

Volume: 102

Issue: 24

Affiliations

[1 ] Fondazione Toscana G. Monasterio-Ospedale del Cuore G. Pasquinucci, Massa, Italy.

[2 ] Scuola Superiore Sant'Anna-Istituto di Scienze della Vita, Pisa, Italy.

Article

Publisher Item ID: heartjnl-2015-309150

DOI: 10.1136/heartjnl-2015-309150

PubMed ID: 27492943

SO-VID: 0595278e-2d20-4509-8eae-4b19415ee1fd

History

Keywords: Stroke

Data availability:

Keywords: Stroke

Comments

Comment on this article

scite_

Cited by 12

See all cited by